Stocks and InvestingStocks and Investing
Mon, October 25, 2021
Sun, October 24, 2021
Fri, October 22, 2021
Thu, October 21, 2021

Matthew Taylor Maintained (ABT) at Strong Buy with Increased Target to $138 on, Oct 21st, 2021


Published on 2024-10-27 18:15:18 - WOPRAI, Matthew Taylor
  Print publication without navigation


Matthew Taylor of UBS, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $131 to $138 on, Oct 21st, 2021.

Matthew has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Simon Baker of "Redburn Partners" Initiated at Hold on, Thursday, October 14th, 2021


These are the ratings of the 6 analyists that currently disagree with Matthew


  • Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $143 on, Wednesday, October 20th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $135 on, Sunday, October 10th, 2021
  • Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $140 on, Friday, October 8th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy and Held Target at $133 on, Tuesday, August 31st, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Friday, July 23rd, 2021
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021